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Background and objectives: Previous studies have demonstrated that serum NT-proBNP was 
lower in the general population with MetS. NPs are a set of peptide-hormones that are well known for 
their role in cardiovascular homeostasis. The present study aims at determining the NT-proBNP serum 
levels in patients who have MetS in comparison to subjects apparently healthy and inhabiting Duhok 
city/ Kurdistan Region/Iraq. 
Methods: A cross sectional research was conducted between 1st of June 2019 and 29th of May 
2020 at Duhok Diabetic Clinic. NT-pro BNP level was determine in 80 subjects with MetS (20 Males 
and 60 Females; 20-70 years) and 20 apparently healthy subjects. The data were analyzed by using the 
SPSS software version 23.T-test was used to compare between proportions. 
Results:The mean ± SD of all demographic parameters (WC, SBP, and DBP) were significantly 
higher in subjects with MetS in comparison to apparently healthy subjects except age which was none 
significant.The parameters of biochemistry(triglyceride, TC,FBS, and insulin) in subjects with MetS also 
were substantially higher compared to apparently healthy subjects with the exception of HDL-C and NT-
proBNP, which in apparently healthy subjects were higher compared to the MetS. The current data 
indicate that the NT-proBNP differentiates significantly between ages, BMI, DBP, FBS, and TG, with 
TC (p<0.05). 
Conclusions: Metabolic components are correlated with a lower serum concentration NT-
proBNP. These figure out increase the probability that decreased serum levels of NT-proBNP are an 
indicator of MetS, which could have important pathophysiological and clinical consequences. 
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          Metabolic syndrome is composed of a set of abnormal physical and laboratory 
findings that take place as a result of the integration of physiological, clinical, 
biochemical, and metabolic factors. As a result, atherosclerosis, CVD, and overall 
mortality noticeably increase [1]. 
          The principle physiological and clinical indications of metabolic syndrome are 
represented by reduced high density lipoprotein-cholesterol, elevated TGs, high BP as 
well as increased FBS which are in direct relation to the increase of adipogenesis and 
weight gain at large; and to intra-abdominal and increased waist circumferences [2]. 
MetS is mainly caused by elevated calorie food intake, i.e. lack of exercise and over 
nutrition side by side with some other factors, namely epigenetic, genetic, as well as 
environmental [3], [4], [5].  
NT-proBNP, i.e. the circulating hormones caused by secretion from ventricular 
myocytes, underlines araised ventricular mechanical load and stress and stands for an 
inactive fragment of prohormone proBNP [6],[7]. NT-proBNP represents cardiac 
biomarkers confirmed for the purpose of assessing the left ventricular dysfunction and 
CHF [3]. Individuals with high left ventricular end-diastolic pressure have lower levels 
of NT-proBNP in obese [8]. There is activation of the reninangiotensin-aldosterone 
system in obese patients [9]. There is binding of the common receptor, guanylyl 
cyclase-A by the brain natriuretic peptide. This results in biologic actions via a cGMP-
dependent pathway which practices a restraining impact on the RAAS axis [10]. 
Accordingly, the RAAS may be activated by low levels of natriuretic peptide. This may 
add to metabolic syndrome development in obese people in particular [11]. 
Two studies byLi et al. (2011) and Sezen et al. (2009) indicated a level of NT-
proBNP in metabolic syndrome similar to that in normal subjects. This is on one 
hand[12], [13]. On the other hand, Olsen et al. (2005) found out a decreased level of 
NT-proBNP level in MetS side by side with a blunted NT-proBNP pulse pressure 
relationship in these patients[14].  
In the current study, the role of NT-proBNP has been studied from different 
perspectives so as to shed light on the pathophysiological impact of hypertension as a 
component of MetS in the subject; which has a great function in the development of 
CVD. Since this study endeavors to predict the role of a significant potential risk factor, 
especially in subjects with metabolic syndrome, it may be the seminal work carried out 
in the Region as it focuses on subjects with metabolic syndrome and others who are 
apparently healthy in Duhok /Kurdistan Region/Iraq. 
 
Patients and method 
Biochemical analysis 
Estimation of serum NT-pro BNP 
Detection of serum NT-pro BNP, TC, HDL-C, triglyceride, insulin and blood 
glucose using specific kit (Roche) according to company protocol instructions using 
cobas 6000 autoanalyzer machine[15]. 
Statistical analysis 
          Through the SPSS software version 23 the data were analyzed and indicated as 
the normal and mean division. In comparison with proportions, T-test was used. In 
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addition, one-way variance analysis (ANOVA) was used to compare different groups. 
Pearson correlation was used for the estimation of the relationship between variables. 
A p-value of < 0.05 has been statistically important in all experiments. 
Results 
The current study comprises 100 subjects, 80 with metabolic syndrome and 20 
apparently healthy subjects. Table 1 demonstrates the laboratory and demographic 
properties of the study subjects. The mean ± SD of all demographic parameters (BMI, 
SBP and DBP) in patients with metabolic syndrome were substantially higher relative 
to relatively healthy people, with the exception of age, which did not matter. Same 
while biochemical parameters (triglyceride, TC,FBS, insulin, and HOMA-IR) were 
significantly higher in subjects with MetS in comparison to apparently healthy subject 
except HDL-C and NT-proBNP which were higher in apparently healthy subject in 
comparison to metabolic syndrome. 
 
Table 1 general characteristic features of study population. 
Study Variables 










Male 20 (25%) 10 (50%)  
Female 60 (75%) 10 (50%)  
Age (years) 50.61 ± 10.90 51.20 ±11.53 NS 
BMI (kg/m2) 34.83 ± 5.89 23.15 ± 1.12 < 0.001 
Waist circumference (cm) 114.53 ± 10.62 90.95 ± 6.63 < 0.001 
SBP (mmHg) 139.81 ± 17.61 118.00 ± 5.71 < 0.001 
DBP (mmHg) 87.62 ± 8.03 77.25 ± 3.79 < 0.001 
Cholesterol (mg/dl) 182.33 ± 42.09 150.65 ± 31.21 < 0.01 
Triglyceride (mg/dl) 226.23 ± 132.91 105.30 ± 29.63 < 0.001 
HDL- Cholesterol (mg/dl) 37.88 ± 8.07 45.30 ± 8.50 <0.01 
FBS (mg/dl) 195.53 ± 67.62 90.60 ± 7.45 < 0.001 
Insulin (μU/mL) 36.31 ± 24.28 6.65 ± 1.87 < 0.001 
HOMA-IR 17.23 ± 12.43 1.40 ± 0.40 < 0.001 
NT-proBNP (pg/ml) 36.31 ± 13.68 53.05 ± 11.62 < 0.001 
 
Serum NT-proBNP and waist circumference (WC) 
          Table 3.5 illustrates the mean±SD of serum NT-proBNP levels ranked on the 
base of by waist circumference. Patients and apparently healthy subjects with central 
obesity had lower levels of serum NT-proBNP in comparison to those with normal 
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(WC) <102 cm in 
male, <88 cm in 
female (N=20) 
(WC) ≥102 cm in 




53.05±11.68 36.31±13.68 <0.001 
 
Serum NT-proBNP and systolic blood pressure (SBP) 
Regarding systolic blood pressure, Table 3 demonstrates that there was no 
statistically significant distinction in NT-proBNP between high systolic blood pressure 
subjects in comparison with normal subjects (P>0.05). 
 






SBP <130 mmHg 
(N=43) 




38.60±18.88 40.45±11.01 NS 
 
Serum NT-proBNP and diastolic blood pressure (DBP) 
Regarding DBP, Table 4 demonstrates thatpatients with normal DBP and apparently 
healthy subjects got a mean of the serum NT-proBNP level (p< 0.001) that was 
significantly higher in comparison to the subjects with high DBP. 
 





DBP <85 mmHg 
(N=40) 
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Serum NT-proBNP and fasting blood sugar (FBS) 
The mean±SD of the levels of serum NT-proBNP ranked on the basis of fasting 
blood sugar is presented in Table 5. Patients and apparently healthy subjects with high 
blood sugar had lower levels of serum NT-proBNP in comparison to those with normal 
group (p< 0.001). 
 




Serum FBS level <100 
mg/dl (N=20) 




53.05±11.66 36.31±13.68 <0.001 
 
Insulin and serum NT-proBNP  
          The mean±SD of the levels of serum NT-proBNP ranked according to insulin is 
shown in Table 6. Patients and apparently healthy subjects with normal insulin had 
higher levels of serum NT-proBNP in comparison to those with high insulin group (p< 
0.05). 
 





Level of Serum 
insulin  
<24.9 μU/mL (N=46) 
Level of Serum 
insulin  
≥24.9 μU/mL   (N=54) 
NT-proBNP 
(Pg/ml) 
43.80±15.65 36.12±13.29 <0.05 
 
Serum NT-proBNP and HDL-cholesterol  
Table 8 illustrates the mean±SD of the levels of serum NT-proBNP ranked according 
to the HDL-cholesterol. There was no significant relation in NT-proBNP between 
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Level of Serum HDL-
C<40 (mg/dl) in male, 
<50 (mg/dl) in 
female(N=72) 
Level of Serum HDL-
C ≥40 (mg/dl) in male, 




38.84±14.91 41.75±14.78 NS 
 
Serum NT-proBNP and triglyceride (TG)  
          Regarding triglyceride, Table 7 demonstrates that there was a highly significant 
relation in serum NT-proBNP levels (p< 0.01).  
 




p- value Level of Serum 
TG<150 mg/dl (N=45) 
Level of Serum 
TG≥150 mg/dl (N=55) 
NT-proBNP 
(Pg/ml) 
44.06±14.63 36.05±14.16 <0.01 
 
Correlation analysis 
According to Pearson correlation coefficient (r), there were significant negative 
correlation of NT-proBNP with BMI, DBP, TC, triglyceride, fasting blood sugar, 
insulin and HOMA-IR. Furthermore, NT-proBNP was significantly positive 
correlations in age. On the other hand, NT-proBNP shows non-significant correlation 
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Table 9 correlation between NT-proBNP (pg/ml) and Study Population 
Parameters. 
 


























The current study is the principal cross sectional study that estimates the serum 
NTproBNP level among patients with metabolic syndrome in Duhok city. It has put 
forward clear evidence that subjects with Mets had lower levels of NTproBNP in 
comparison to apparently healthy subjects. The results also confirm a negative 
association between serum NTproBNP levels and the whole metabolic syndrome 
components save elevated blood pressure and HDL-cholesterol. 
          Wang et al. (2007) analysed the association between serum levels of BNP and 
the metabolic risk factors in 3333 Framingham study participants who had no heart 
failure. It was found out that BNP had positive association with SBP and HDL-C, yet 
its association with BMI, DBP, total cholesterol, fasting glucose and insulin resistance 
was negative[16]. Olsen et al. reported similar findings in a large-scale Danish 
investigation [14] and arrived at results that were compatible with the results of the 
current research. However, to the present researcher’s best knowledge, this study is 
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viewed as the pioneering one in terms of examining the individual and collective effects 
of serum NT-proBNP levels among subjects with metabolic syndrome in Duhok, 
Kurdistan Region (Iraq).  
 
Serum NT-proBNP and obesity 
          In the whole population of the current study,levels of serum NT-proBNP were 
significantly higher in normal weight in comparison to overweight and obese (p< 0.001) 
(Table 3.4). In spite of that, again in the whole study population, there had been lower 
levels of serum NT-proBNP in persons having central obesity compared to the normal 
group (p< 0.001) (Table 3.5). There was also a significant negative correlation between 
BMI and waist circumference (r= -0.350, p<0.001; r= -0.401, p<0.001) in both (MetS 
subjects and apparently healthy subjects) respectively (table 3.15). 
          As already highlighted, there is a close link between the NP system and adiposity 
[17], [18]. The abundant availability of NP clearance receptors in adipose tissue 
[19]suggests adipocytes participation in removing NPs from the circulation. On this 
basis, there is an increase of the clearance of natriuretic peptide concomitant with the 
possible occurrence of a condition of decreased NP concentration in obese patients. 
Added to that, there are potential ipolytic impacts of NPs in the isolated human fat cells 
and in adipocytes in vivo through cyclic guanosine monophosphate (cGMP)-medicated 
phosphorylation [20]. Hence, there could be an increase inskeletal muscle and lipid 
accumulation in adipose tissue [21], and the perpetuation of the obese state by a reduced 
NP signalling. 
          In the cohorts of the Framingham Heart Study, people who are obese had lower 
serum BNP levels compared to those with normal weight [17].Also recently, there has 
been a negative association between serum BNP and BMI[17], [22].  
 
Blood pressure andserum NT-proBNP  
          It has been illustrated that in the whole population of the current study the serum 
NT-proBNP levels were significantly higher in normal diastolic blood pressure in 
comparison to the abnormal group (p< 0.001) (Table 3.7). This is on one hand. On the 
other hand, concerning NT-proBNP levels, there was no significant relation in NT-
proBNP between subjects with high SBP and those in the normal group (p> 0.05) (Table 
3.7).   
There was a negative correlation betweenlevels of serumNP and all the 
components of MetS except elevated blood pressure and HDL-C. Just opposite to other 
metabolic factors, in Li’s study, there was an association between elevated SBP and 
higher BNP levels [13].In line with such data, the current study has come out with the 
finding that there was an association between the low serum NT-proBNP levels and 
almost all the components of the Mets save the elevatedSBP as there was an association 
with higher serum NT-proBNP levels. This indicates that there is a 
haemodynamicimpact of blood pressure on the NP synthesis. The oversight that there 
are more different relations between serum NT-proBNP levels and SBP than to other 
metabolic components proposes the separate segregation of blood pressure from other 
MetS components [23]. In their Insulin Resistance Atherosclerosis Study, Hanley et al. 
[23] a head factor analysis was used for the identification of 2 "factors", namely a 
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metabolic factor that consisted ofglycaemic measures, BMI, triglycerides, and HDL-C, 
and a blood pressure factor which comprised DBP and SBP . There was also a 
correlation between fasting insulin and the metabolic factor, but not with that of the 
blood pressure.  
 
Blood glucose, insulin and serum NT-proBNP 
The current study indicates that in normal heart peoples, a negative association 
existed between fasting blood sugar and insulin on one hand and with serum Nt-proBNP 
levels in contrast. Added to that, the level of serum NT-proBNP levels were 
significantly lower in patients of MetS subgroups ranked according toFBS and insulin 
than the apparently healthy subjects. In the whole study population, lower mean values 
of serum NTproBNP levels were found in the patients and apparently healthy subjects 
with high blood sugar and high insulin levels in comparison to those in the normal 
group, at the time when the differences were statistically significant (p < 0.001) (p < 
0.05) (Table 3.8, 3.9). 
          According to Baoet al. (2011) there was an inconsistent relationship between 
fasting glucose and BNP[24]. They found out a negative association between fasting 
glucose and NT-proBNP. However, inOlsen et al.’s study (2005).There was a 
consistent inverse relationship between insulin level and NTproBNP level. It has been 
suggested by some experimental perceptions that low NP levels could predispose to 
insulin resistance (IR)[14]. Johnston et al. (1989) stated that a greater activation of the 
renin-angiotensin system could be resulted from a reduced natriuretic peptide 
activity[25].  Also, the improvement of insulin resistance via various mechanisms is 
promoted by the activation of the renin-angiotensin system [26]; hence subsuming the 
inhibition of intracellular insulin signalling, enhancement ofinflammation, oxidative 
stress, reduce of adipocyte differentiation, and a diminishedperfusion to the pancreas 
and skeletal muscle. 
 
Serum NT-proBNP and lipid profile 
In this study, lipid profile was investigated in subjects with Mets and apparently 
healthy subject. The comparison between groups illustrated that serum total cholesterol 
levels varied significantly among groups (metabolic syndrome: 182.33 ± 42.09 mg/dl, 
apparently healthy subject: 150.65 ± 31.21mg/dl, P< 0.01). The same result was 
obtained for triglyceride (metabolic syndrome: 226.23 ± 132.91 mg/dl, apparently 
healthy subject: 105.30 ± 29.63 mg/dl, p < 0.001). in contrast, the variation in serum 
HDL (metabolic syndrome: 37.88 ± 8.07 mg/dl, apparently healthy subject: 45.30 ± 
8.50 mg/dl, p < 0.01 (Table 3.1). as we illustrated in (table 3.11, 3.12) patients and 
apparently healthy subjects with high cholesterol and high  triglyceride had lower levels 
of serum NT-proBNP in comparison to those with normal weight (p < 0.05). in contrast, 
no statistically significant distinction in Nt-proBNP was found between subjects with 
low HDL-C and normal group  (p > 0.05) (Table 3.13).  
          In the previous large-scale investigations, a negative correlation was found 
between serum NT-proBNP as well as serum total cholesterol and triglyceride, yet the 
association was positive with HDL-C [16].The causal relationship between natriuretic 
peptide and cholesterol or triglyceride is unclear and might not be direct. There could 
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be promotion of lipid accumulation inskeletal muscleand adipose tissue by reduced 
natriuretic peptide signalling could promote [21] whichresults in the advancement of 
visceral adiposity that are associated with dyslipidemia. 
 
Conclusions 
On the basis of the results arrived at by the present study, it is concluded that: 
➢  The majority of the study participants were female, obese and overweight, 
abnormalwaistcircumference and hyperglycemia. 
➢  Metabolic components are correlated with a lower serum concentration NT-
proBNP. These figure out increase the probability that decreased serum levels of 
NT-proBNP are an indicator of MetS, which could have important 
pathophysiological and clinical consequences. 
➢  HighBMI, waistcircumferences, DBP, FBS, insulin, cholesterol and triglyceride 
levels showed low levels of NT-proBNP levels.  
➢  There were significant association betweengender, age, components of metabolic 
syndrome and serum NT-proBNP. 
➢  Serum NT-proBNP is negatively correlated withBMI, TC, Triglyceride, blood 
glucose, insulin, DBP and HOMA-IR.  
➢  NT-proBNP had a significant positive correlation with age. 
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تيرمينال برو برين ناتريورتيك بيبتايد كان أقل في عموم السكان الذين لديهم -أظهرت الدراسات السابقة أن مصل ن الخلفية واألهداف:
متالزمة االيض مقارنة باألشخاص األصحاء ظاهريا. ناتريورتيك بيبتايد هي عبارة عن مجموعة من هرمونات الببتايد المعروفة جيدا 
تيرمينال برو برين ناتريورتيك بيبتايد  في -موية. تهدف الدراسة الحالية إلى تحديد مستويات مصل نبدورها في توازن القلب واألوعية الد
  المرضى الذين لديهم متالزمة االيض مقارنة باألشخاص األصحاء ظاهريا المقيمين في مدينة دهوك / إقليم كردستان / العراق. 
في مركزامراض السكر بمدينة دهوك. تم تحديد  29/5/2020و  1/6/2019تم إجراء بحث مقطعي في الفترة ما بين  طريقة العمل:
عاما( و  70-20، أنثى 60ذكر و 20متالزمة االيض ) شخصا لديهم 80تيرمينال برو برين ناتريورتيك بيبتايد في -مستوى مصل ن
 -مج )اس بي اس اس(. تم استخدام )تيمن برنا 23شخصا يبدو أنهم يتمتعون بصحة جيدة. تم تحليل البيانات باستخدام اإلصدار  20
 تيست( للمقارنة بين النسب.
وضغط الدم االنقباضي وضغط الدم االنبساطي(  محيط الخصراظهرت النتايج ان معدل عامل التلف لجميع القيم الديموغرافية ) النتائج:
أعلى بشكل ملحوظ في األشخاص الذين لديهم متالزمة االيض مقارنة باألشخاص األصحاء ظاهريا باستثناء العمر، والذي لم يكن ذات 
األنسولين( في األشخاص الذين ، و نسبة كيمياء الحيوية )الدهون الثالثية، الكوليسترول الكلي، نسبة السكر في الدم. كانت قيم العالقة
-باستثناء )كوليسترول البروتين الدهني عالي الكثافة و ن ضاهريا يعانون من متالزمة االيض أعلى أيضا مقارنة باألشخاص األصحاء
تالزمة االيض. م اشخاص الذين لديهم ، والتي كانت أعلى في األشخاص األصحاء ظاهريا مقارنة معال برو برين ناتريورتيك بيبتايد(تيرمين
، ضغط الدم تايد يفرق بشكل كبير بين األعمار، مؤشر كتلة الجسمتيرمينال برو برين ناتريورتيك بيب-تشير البيانات الحالية إلى أن ن
 (0.05اقل من  Pالدهون الثالثية, والكوليسترول الكلي )نبساطي، نسبة السكر في الدم، و اال
تيرمينال برو برين ناتريورتيك بيبتايد. وهذا يظهر زيادة -رتبطة مع سيرم منخفضة التركيز ل نالمكونات االيضية تكون م االستنتاجات:
تيرمينال برو برين ناتريورتيك بيبتايد المنخفضة هي مؤشر على متالزمة االيضية، والتي يمكن أن -االحتمالية بأن مستويات مصل ن
 يكون لها عواقبسريرية ومرضية فسيولوجية.
 
